Saint Luke’s Marion Bloch Neuroscience Institute Announces Inaugural Stroke & Cerebrovascular Conference

Share Article

Conference will focus on multidisciplinary approach to patients with stroke and aneurysm

Stroke and Cerebrovascular Conference

There have been significant advances in the diagnosis and treatment of stroke. The program will emphasize evidence-based strategy for current treatment and research, as well as advances in medical and neuro interventional approaches to stroke.

Saint Luke’s Marion Bloch Neuroscience Institute, one of the region’s premier neuroscience facilities, in conjunction with the Institute for International Medicine (INMED) and Saint Luke’s Hospital of Kansas City, will present its Inaugural Stroke & Cerebrovascular Conference on Friday, Oct. 23, 2015, at the InterContinental Kansas City at the Plaza.

The program will focus on the multidisciplinary approach to patients with stroke, including prevention, imaging, and a variety of treatment modalities from pre-hospital to operating room. The conference will feature presentations by Saint Luke’s faculty members, as well as special guest presenters, including internationally renowned stroke specialists James C. Grotta, M.D., who will present on moving acute stroke treatment to the pre-hospital arena, and Andrei V. Alexandrov, M.D., who will speak about advances in stroke imaging.

“Saint Luke’s is committed to providing the best evidence-based treatment for stroke. In recent years there have been significant advances in the diagnosis and treatment of stroke,” said Stanley P. Fisher, M.D., co-director of the Neuroscience Institute. “This program will emphasize the evidence-based strategy for current treatment and leading-edge research, as well as advances in medical and neuro interventional approaches to stroke.”

Presenters will speak on a variety of topics, including sessions on:

  •     Stroke in young adults
  •     Mobile Stroke Unit: moving acute stroke treatment to the pre-hospital arena
  •     Approach to stroke prophylaxis in patients with atrial fibrillation
  •     Percutaneous device therapy for stroke prevention
  •     Advances in stroke imaging
  •     Neuro intervention: parallel pathways to interventional stroke therapy
  •     Advances in treatment of intracerebral hemorrhage (ICH)
  •     Use of robotically assisted gait training in stroke recovery

The conference has been planned and implemented in accordance with the Essential Areas and Policies of the Missouri State Medical Association through the joint providership of INMED and Saint Luke’s Hospital of Kansas City. Continuing education credits will be offered to physicians, physician assistants, advanced nurse practitioners and other healthcare professionals with an interest in neurology. The conference benefits primary care physicians, neurologists, neurointensivists, neuroradiologists, physiatrists, neuroscience nurses, and EMS providers. For more information and to register, visit saintlukeskc.org/stroke-conference.

Saint Luke’s Marion Bloch Neuroscience Institute(SLMBNI) is a comprehensive center for neuroscience research, education, and evidence-based medicine that combines faculty in neurology, neurosurgery, interventional neuroradiology, neurootology, psychiatry, and physical medicine and rehabilitation. Together SLMBNI faculty provides patient-centered leading-edge care to thousands of patients from all over the country each year. As a member of Saint Luke’s Health System, SLMBNI is a global leader in utilizing both drug and mechanical interventions to reverse the permanent and debilitating effects of ischemic stroke. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse strokes in thousands of patients through its network of stroke centers. Located in Kansas City, Mo., SLMBNI brings together a team of highly specialized neuroscientists to provide comprehensive treatment for the most complex neurological diseases, including stroke, epilepsy, brain tumors, Parkinson’s and Alzheimer’s diseases, multiple sclerosis, headaches and facial pain, as well as aneurysms and intracerebral hemorrhages. The Institute’s multispecialty team provides the latest in minimally invasive spinal surgical techniques for the treatment of acute and chronic back pain. SLMBNI strives to be a national leader in neurological treatment and care by advancing clinical research and evidence-based clinical practice.

Saint Luke’s Health System consists of 10 area hospitals and several primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the Kansas City metropolitan area and the surrounding region.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Manuel
Saint Luke's Health System
+1 (816) 502-8533
Email >